[Form 4] CELESTICA INC Insider Trading Activity

Rhea-AI Filing Summary

Robert Cascella, a director of Celestica Inc. (CLS), was granted 157 restricted share units (RSUs) on 09/30/2025. Each RSU represents a contingent right to one common share or equivalent cash at the holder's election. The grant vests one-third annually over three years beginning on the anniversary of the grant. Following the grant the reporting person beneficially owns 157 common shares (direct). The RSUs were granted at a $0 per-unit price (no cash paid by the reporting person) and are subject to the stated vesting schedule.

Positive

• Director alignment: Grant of 157 RSUs aligns the reporting director's incentives with shareholders through equity-based compensation
• Retention feature: Vesting schedule of one-third annually over three years supports continued service

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity grant aligns long-term interests with shareholders without immediate dilution.

This 157-RSU award to a director is a standard compensation mechanism to tie non-employee directors to company performance and retention. The one-third-per-year vesting over three years encourages continued service. Because each RSU is a contingent right to one share or cash, ultimate dilution depends on whether shares or cash are delivered, which is not specified. The grant size appears modest relative to typical director awards, suggesting routine governance practice rather than a material corporate event.

Securities Analyst

TL;DR: Small, non-cash RSU award recorded; immaterial to Celestica's capital structure in isolation.

The filing documents a 09/30/2025 grant of 157 RSUs to a director, with 157 common shares beneficially owned post-grant and a reported $0 per-unit price in the table. This is a standard equity-based compensation disclosure under Section 16 and does not report any exercised or disposed transactions. In the absence of additional grants, exercises, or share-delivery details, this single grant is unlikely to have a material impact on outstanding shares or earnings per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

CASCELLA ROBERT

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO A6 M2N 6L7

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	09/30/2025		A		157		(2)	(2)	Common Shares	157	$0	157	D

Explanation of Responses:

1. Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

2. On September 30, 2025, the reporting person was granted 157 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

	/s/ Tracy Connelly McGilley, attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CELESTICA INC (CLS) report on Form 4 filed for Robert Cascella?

The filing reports a grant of 157 restricted share units (RSUs) to director Robert Cascella on 09/30/2025, with one-third vesting annually over three years.

How many shares does Robert Cascella beneficially own after the reported transaction?

The reporting person beneficially owns 157 common shares following the reported grant.

What is the economic nature of the RSUs granted to the director?

Each RSU represents a contingent right to receive one common share or an equivalent cash value at the holder's election.

What was the reported price for the RSU grant on the Form 4?

The table lists a price of $0 for the RSU grant (equity award grant, no cash paid by the reporting person).

When do the RSUs granted to Robert Cascella vest?

The RSUs vest one-third on each anniversary of the 09/30/2025 grant date over three years.